IBI SA is partner of the month of TEDD!
IBI has been nominated as “partner of the month” by the competence centre TEDD (Tissue Engineering for Drug Development and substance […]
CLOSE
IBI has been nominated as “partner of the month” by the competence centre TEDD (Tissue Engineering for Drug Development and substance […]
The Sole 24 Ore, an Italian national daily business newspaper, talks for the third time about Smartbone® in the article entitled […]
The Sole 24 Ore, an Italian national daily business newspaper, talks for the third time about Smartbone® in the article entitled […]
Il Sole 24 Ore, an Italian national daily business newspaper, talks for the second time about Smartbone® in the article […]
Doctor Gianni Pertici CEO and founder of IBI SA was recently interviewed by RTS (Radio Télévision Suisse) during the […]
The story of IBI SA has been recently featured in the german magazine Wirtschaftsforum. From the beginning to the future […]
In June 2017, SmartBone® on Demand™ engaged successfully in an enormously complex maxillofacial surgical challenge. The innovative bone substitute designed […]
In May 2016, SmartBone® on Demand™ engaged successfully in a complex cranial surgical challenge. The innovative bone substitute designed by Industrie Biomedriche […]
Visit the website! Industrie Biomediche Insubri SA (IBI) in a collaboration with The Pharmaceutical and Biomedical Technologies laboratory, within the Institute CIM […]
In November 2013, Smartbone On Demand engaged successfully in a complex maxillo-facial surgical challenge. The innovative bone substitute designed by […]
IBI’s Production and R&D Specialist Luca Orlando obtained today his Second Degree in Engineering with a dissertation titled “Analysis of […]
Il Sole 24 Ore, an Italian national daily business newspaper owned by Confindustria, talks about Smartbone in its article titled […]
IBI S.A.
Industrie Biomediche Insubri S.A.
via Cantonale 67, CH-6805 Mezzovico-Vira, Switzerland
t. +41 91 93.06.640
f. +41 91 220.70.00
